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The thyroid hormone receptor (TR) a nuclear receptor that is essential for the proper regulation 
of metabolism and development, as it regulates gene expression in response to thyroid 
hormone contains nuclear localization signals (NLSs) and nuclear export signals (NESs) that 
allow for TR transport into and out of the nucleus, respectively. Previous research has shown that 
nuclear import, nuclear retention, and nuclear export of TR are associated with modulation of 
gene expression, the alteration of which can contribute to various diseases, including Resistance 
to Thyroid Hormone (RTH) Syndrome, type II diabetes mellitus, and several types of cancer. 
transfection of expression plasmids for green fluorescent protein (GFP)-tagged TR and 
in patients with hepatocellular carcinoma and papillary thyroid cancer and are associated with 
NLSs a -to-cytoplasmic ratios of 
1 mutations on receptor localization within HeLa 
cells. We found that, while wild-type TR has a primarily nuclear localization with a smooth 
and A225G, D246N, G350K lead to significantly decreased nuclear-to-
ggregates. We observed that the 




thyroid hormone-dependent genes. These results contribute to an improved understanding of TR 
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Thyroid hormone receptor (TR) regulates processes that are essential for normal growth and 
development and help maintain homeostasis in adults (Zhang and Lazar, 2000). Thyroid 
hormone receptors are members of the nuclear receptor superfamily that serve as ligand-
dependent transcription factors (Aranda and Pascual, 2001). Ligand-dependent transcription 
factors are proteins that modulate transcription when bound to other molecules, such as 
hormones, and to regulatory sequences of DNA. In the case of TR, binding of thyroid hormone 
(TH) to TR modulates the transcription of target genes, which allows for the synthesis of proteins 
that help regulate metabolism and development (Zhang and Lazar, 2000). This thesis focuses on 
the impact of six cancer-associated mutations in a subtype of TR on its localization and 
function. 
Secretion of Thyroid Hormone 
TH is secreted by the thyroid gland through hypothalamic-pituitary axis regulation. The 
hypothalamus secretes thyrotropin-releasing hormone (TRH), which binds to a G protein-
coupled TRH receptor and stimulates the pituitary gland to release thyrotropin-stimulating 
hormone (TSH). TSH binds to thyroid follicular cell and induces the production and release of 
TH, specifically thyroxine (T4 -l-tetraiodothyronine) and triiodothyronine (T3 -l-
triiodothyronine). T4 and T3 are tyrosine-based hormones, with the numbers 3 and 4 referring to 
the number of iodine molecules in each compound. T4 is thought to be a precursor molecule for 
T3 which is more potent, as T3 binds to TR and regulates transcription (  et al., 
2011). Thyroid hormone circulates through the bloodstream by binding to a carrier protein and 
enters cells through membrane transporters such as the monocarboxylate transporter MCT8. 
After entering cells, thyroid hormones can be modified by deiodinases. Deiodinases either 
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activate prohormone T4 by converting T4 to T3, or they inactivate T4 by converting it to reverse 
T3 (rT3; -l-triiodothyronine) to ensure that tissues are not damaged by excess hormones 
(Anyetei-Anum et al., 2018). Having the proper concentration of each type of TH within cells is 
important because TH primarily functions by binding to thyroid hormone receptors and helps 
regulate gene expression. 
Subtypes of Thyroid Hormone Receptors 
In humans, there are two TR genes: THRA and THRB. Through differential RNA splicing, THRA 
THRB 
brain, muscle, heart, bone, and gastrointestinal tract
liver, kidneys, hypothalamus, pituitary, and retina (Bochukova et al., 2012). 
Domains of TR 
As a nuclear receptor, TR has four domains: N-terminal A/B domain, DNA-binding domain 
(DBD), hinge region, and C-terminal ligand-binding domain (LBD) (Figure 1). The N-terminal 
A/B domain is involved in the recruitment of coregulatory proteins such as coactivators and 
corepressors (Tsai and . The A/B domain has the transactivation domain 
activation function 1 (AF1), which is responsible for transcription regulation in a ligand-
independent manner (Zhang and Lazar, 2000)
localization signal (NLS) called NLS-2 (Mavinakere et al., 2012). The DNA-binding domain, 
also known as the C domain, of TR interacts with particular DNA sequences known as thyroid 
hormone response elements (TREs) in the enhancer regions of target genes via two zinc 
3 
finger motifs, ensuring that only the expression of specific genes is altered (Tsai and 
1994). The C domain is also important for heterodimerization with retinoid X receptor (RXR), 
which stabilizes DNA binding (Lazar, 2003). The hinge domain, also known as the D domain, is 
a flexible connection between C and E/F domains that contributes to DNA binding, ligand 
binding, and interactions with corepressors (Nascimento et al., 2006)
contains NLS-1 (Mavinakere et al., 2012). The C-terminal LBD, also known as the E/F domain, 
of TR binds to TH, which leads to conformational changes in TR and modifies TR activity (Tsai 
and . The LBD also functions as a receptor dimerization surface that binds to 
coregulators, and it has an activation function 2 (AF2), which facilitates ligand-dependent 
transactivation (Zhang and Lazar, 2000). The LBD has three nuclear export signals (NES-H3, 




Expression of Target Genes by TR 
Once bound to DNA, TR usually heterodimerizes with RXR. When TR interacts with positive 
TREs and is not bound to TH, corepressors such as histone deacetylase (HDAC), N-CoR1, or 
N-CoR2 are bound to TR, causing the transcription of target genes to be repressed. When TH 
binds to TR, TR goes through a conformational change, allowing activator proteins such as 
histone acetyltransferase (HAT) and steroid receptor coactivator 1 (SRC1) to bind to TR, 
which alters chromatin structure and promotes target gene expression. On the other hand, TRs 
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can also bind to negative TREs. In this case, corepressors are recruited to TR when bound to TH 
and coactivators are recruited to TR when not bound to TH (Ortiga-Carvalho et al., 2005). 
Helix 12 of LBD 
-helices and undergoes ligand-dependent conformational 
changes. In particular, helix 12 has the ligand-dependent AF2, which mediates transactivation by 
RXR. Helix 12 forms two hydrophobic cavities that can bind to hormones. When TR is bound to 
positive TREs, helix 12 is extended and binds to a corepressor through the corepressor nuclear 
receptor (CoRNR) box motifs of the corepressor. Once T3 binds, helix 12 closes around T3 and 
forms a region that interacts with coactivators. Modifying the structure of helix 12 can change its 
specificity to and interactions with corepressors (Anyetei-Anum et al., 2018). 
Nuclear Transport of TR 
Thyroid hormone receptors are primarily present in the nucleus, but they are known to shuttle 
between the cytosol and nucleus. 
nucleus with an apparently constant shuttling of TR between the nucleus and cytoplasm. Proper 
nuclear export and nuclear import is crucial for the regulation of TR target gene expression. 
Thyroid hormone receptor is shuttled into and out of the nucleus through nuclear pore complexes 
(Mavinakere et al., 2012). The nuclear pore complex (NPC) a large assemblage of proteins that 
is embedded in the nuclear envelope selectively allows for nuclear import and nuclear export 
of molecules that are larger than 40 kilodaltons (kDa). NPCs consist of approximately 30 types 
of proteins called nucleoporins (Nups), which combine to create an aqueous channel that allows 
certain proteins to be transported between the nucleus and cytoplasm (Beck and Hurt, 2017). 
These 30 proteins can be classified into three groups: the first group includes nucleoporins that 
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have cadherin- -helices, which help anchor NPCs to the 
nuclear envelope; the secon - -propeller structures 
that facilitate interactions among nucleoporins; and, the third group are nucleoporins that have 
phenylalanine-glycine (FG)-repeats. These FG-repeats are crucial for the selective barrier 
function of NPCs, considering that phenylalanine and glycine are hydrophobic amino acids that 
interact with each other and with transport proteins that carry molecules into and out of NPCs 
(Devos et al., 2006). 
While nucleocytoplasmic transport of ions and molecules that are less than 40 kDa occurs 
through passive diffusion, transport of molecules that are larger than 40 kDa requires receptor-
mediated translocation (Veldman and Yang, 2017). Nuclear transport proteins, which include 
importins and exportins, are known as karyopherins. Karyopherins recognize nuclear localization 
signals (NLSs) (for import of molecules into the nucleus) and nuclear export signals (NESs) (for 
export of molecules out of the nucleus) (Cook et al., 2007).  
Nuclear Import: An importin binds to the NLS of a cargo protein in the cytoplasm and passes 
through a nuclear pore complex. Once the bound importin enters the nucleus, it interacts with 
RanGTP and undergoes a conformational change which causes the importin to detach from the 
cargo protein. The importin-RanGTP complex then goes to the cytoplasm, where RanGAP a 
GTPase-activating protein that is located in the cytoplasm and Ran-binding proteins interact 
with the complex to hydrolyze GTP. GTP hydrolysis converts RanGTP to RanGDP. The 
RanGDP-importin complex disassembles, allowing the importin to be available for the nuclear 
import of another protein. RanGDP then binds to a nuclear transport factor and returns to the 
nucleus, where a guanine nucleotide exchange factor (GEF) replaces the GDP in RanGDP with 
GTP, creating RanGTP (Cook et al., 2007). 
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Nuclear export: In the nucleus, an exportin binds to the NES of a cargo protein. RanGTP binds 
to the exportin-cargo complex in the nucleus, forming a trimeric complex that stabilizes nuclear 
export. The trimeric complex exits the nucleus via the nuclear pore complex. In the cytoplasm, 
RanGTP binds to RanGAP which hydrolyzes GTP, allowing the trimeric complex to dissociate. 
The RanGDP returns to the nucleus where it interacts with GEF to form RanGTP (Cook et al., 
2007).  
Protein aggregation 
Protein aggregation occurs when misfolded proteins interact with one another and accumulate 
either within or outside the cell. After being synthesized, proteins normally fold into 
thermodynamically favorable three-dimensional structures in the cytoplasm. In this case, the 
hydrophobic parts of the proteins interact with one another and shield themselves from the 
hydrophilic aqueous surroundings by clustering towards the center of the protein. These 
interactions mean that the outside portion of the folded protein is mostly hydrophilic while the 
inside of the protein is mostly hydrophobic (Dobson, 2003).  
In addition to the covalent peptide bonds between amino acids, the structures of proteins depend 
on non-covalent interactions and di-sulfide bonds within and between proteins. When non-
covalent interactions change, which can occur due to mutations, the protein can be misfolded. If 
the protein does not refold into its native state, proteins can aggregate (Dobson, 2003). Such 
protein aggregation has been previously shown to contribute to the progression of diseases, 




Nongenomic Effects of TR 
In addition to the genomic impacts of thyroid hormone, increasing evidence is emerging of 
nongenomic impacts via receptors in the plasma membrane, mitochondria, and cytoplasm, which 
can be structurally homologous to nuclear receptors (Davis et al., 2016). These nongenomic 
impacts include organization of microfilaments, cell proliferation, and angiogenesis, further 
supporting the hypothesis that TR mutations can impact cancer development (Kalyanaraman et 
al., 2014).  
Relevance of TR Mutations 
Mutated TR was first thought to be associated with cancer after it was discovered that v-ErbA
a retroviral oncoprotein that contributes to carcinogenesis in chickens infected with avian 
erythroblastoma virus (AEV) is a dominant negative mutant of chicken wild-
TR mutants that are associated with disease states are unable to bind to T3, which disrupts proper 
target gene transcription. In addition, mutant TR may display dominant negative activity, in 
which case the mutant TR competes with wild-type TR for DNA binding and prevents normal 
transcriptional activity (Bonamy et al., 2005). TR mutants with dominant negative activity were 
found to be mislocalized to the cytoplasm and form aggresomes (Bondzi et al., 2011). 
Considering that these target genes are linked to development, metabolism, and growth, such 
alterations in the cellular distribution of TR may be contributing to the development of particular 
types of cancer, including hepatocellular carcinoma and papillary thyroid cancer. 
This thesis focuses on describing six cancer- L251P, 













Table 1: Amino acid  The mutations in bold are located in the 
 
 











Mutant 1 S40T A/B Domain Serine Threonine 
K136R Hinge Domain Lysine Arginine 
L251P LBD Leucine Proline 
V390A LBD Valine Alanine 
Mutant 2 L251P LBD Leucine Proline 
Mutant 3 A225G LBD Alanine Glycine 
D246N LBD Aspartic Acid Asparagine 
E350K LBD Glutamic Acid Lysine 
Mutant 4 E213D LBD Glutamic Acid Aspartic Acid 
Mutant 5 G24E A/B Domain Glycine Glutamic Acid 
Mutant 6 K74E DBD Lysine Glutamic Acid 
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Contexts of TR Mutations 
carcinoma (HCC) or papillary thyroid cancer. While high levels of mutations were observed in 
mal tissues, suggesting a 
 (Lin et 
al., 1999). 
: K136R, L251P, V390A are point mutations in NLS-1, 
NES-H3/H6, and NES-
does not correspond to a known NLS or NES. The four point mutations were identified in a 
ed by RT-PCR after isolating truncated TR mRNAs from the 
3-binding activity was completely lost, while its DNA-binding activity was 
normal (Lin et al., 1999). 
: A225G and D246N are point mutations in the NES-H3/H6 
region of TR. G350K is located in the LBD of TR, but it is not in an NLS or NES region. The 
three point 
to be expressed along with full- 3-binding 
activity but normal DNA binding (Lin et al., 1999). 
: G24E is a point mutation in the NLS-2 region of TR. The mutations were 
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mutations (G24E, M256V, 
-
a lack of T3-binding activity but normal DNA-binding activity (Lin et al., 1999). 
: E213D is a point mutation in the NES-H3/H6 region of TR. This mutation was 
found in a tissue obtained from thyroidectomy which was performed following cancer diagnosis; 
histological evaluation confirmed that the patient had papillary thyroid cancer. RNAs were 
isolated from the tumor and mutations were identified through DNA sequencing. Along with the 
iptional activity and 
dominant negative activity (Puzianowska-Kuznicka et al., 2002). 
: 
whose HCC tissues consisted of two mutations (K74E and A264V). The mutations were 
3-binding and DNA-binding activities 









Synthetic gene constructs 
Wild- with antibiotic-resistance were made by GeneArt 
Gene Synthesis. These gene sequences were cloned into a green fluorescent protein (GFP) 
plasmid vector or red fluorescent protein (mCherry) plasmid vector. The expression plasmid for 
caveolin-1, CAV1-mCherry, was a gift from Ari Helenius (Addgene plasmid #27705). 
-1 to be visualized via 
fluorescence microscopy.  
Preparation of Plasmid DNA 
For transformation of plasmids into host bacteria, 1 ng of plasmid DNA was added to competent 
E. coli cells that were thawed on ice for 10 minutes. The tube containing the DNA-E. coli 
mixture was flicked 5 times to ensure that cells adequately mixed with the plasmid DNA. This 
tube was placed on ice for 30 minutes, transferred to a 42 C water bath for 30 seconds, and 
placed back on ice for 5 minutes; this process, which is known as the heat shock method, allows 
the plasmid DNA to be taken up by cells. This mixture was then transferred to a 15 mL tube and 
 pipetted into the tube. The 15 mL tube was placed in a 37 
°C shaking incubator (250 revolutions per minute) for 60 minutes. Meanwhile, antibiotic-agar 
was spread onto a warmed antibiotic-agar plate and incubated at 37 °C overnight; this process 
allows the cells and, thus, the plasmids that were taken up by the cells to multiply. 
Single colonies of E. coli cells from antibiotic-agar plates were added to a mixture containing 3 
the specific antibiotic used in the antibiotic-agar plates; using 
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single colonies increases the likelihood of all plasmids having the same DNA sequence. These 
cultures were placed in a 37 °C shaking incubator (300 revolutions per minute) for 8 hours. 1 mL 
the specific antibiotic. This 
mixture was placed in a 37 °C shaking incubator (300 revolutions per minute) overnight. Then, 
cultures were centrifuged f
Midiprep Kits were used to extract plasmids from the cell pellets. The purity of these plasmids 
was determined by utilizing a Nanodrop® 1000 spectrophotometer. 
Preparation of HeLa cells 
HeLa cells were cultured in Nunc filter-capped flasks containing Gibco Minimum Essential 
Medium (MEM) with Invitrogen 10% fetal bovine serum (FBS). Cells were grown in a 
ThermoScientific incubator at 37 °C under 98% humidity and 5% CO2. 
Seeding and Transfection of HeLa Cells 
In preparation for transfection, approximately 2.5x105 HeLa cells were added onto Fisher glass 
coverslips in each of the wells in a 6-well plate and incubated overnight at 37 °C. The next day, 2 
-  of plasmid DNA (the quantity of which varied based on the experiment) were added to 
Opti-MEM such that the combined volume of plasmid DNA and Opti-
-MEM. Both mixtures were 
incubated at room temperature separately for 5 minutes. Then, both mixtures were combined and 
each of the wells in the 6-well plate. After incubating the 6-well plate at 37 °C for 6-8 hours, the 
media was aspirated, and 2 mL of MEM with FBS was pipetted into each well. The 6-well plate 
was again placed in the 37 °C incubator overnight. 
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Fixation of HeLa Cells 
Twenty-four hours after transfection, MEM with FBS was aspirated off the wells, and the HeLa 
cells were washed with 2 mL of D-PBS for 10 seconds three times. In a Fisher Hamilton fume 
hood, 2 mL of 3.7% formaldehyde solution diluted in 1x D-PBS was added to each well. After 9 
minutes, the formaldehyde solution was pipetted out of each well. The cells were again washed 
three times with 2 mL of 1x D-PBS for 5 minutes. Using tweezers, coverslips were mounted onto 
glass slides using Fluoro-Gel II with DAPI. The slides were kept in a microscope slide box at 4 
°C for at least 24 hours prior to scoring. 
Fluorescence Microscopy 
Glass slides were blinded and examined under an inverted fluorescence microscope using Nikon 
NIS-Elements microscope imaging software on a computer. In the NIS-Elements program, two 
small rectangular Regions of Interest (ROI) were inserted onto a fluorescent cell, with one ROI 
in the nucleus and one in the cytoplasm. To more accurately quantify the intensity of 
fluorescence in the nucleus and cytoplasm, ROIs were placed on representative portions of cells. 
For each experiment, 3-4 biologically independent replicates were performed with a minimum of 
100 cells analyzed per slide. The ratio of nuclear fluorescence intensity to cytoplasmic 
fluorescence intensity was determining by analyzing the data in Microsoft Excel. The difference 
between nuclear and cytoplasmic fluorescence intensity was analyzed for statistical significance 
-test, with p-value of less than 0.05 considered significant. 
Confocal Microscopy and Colocalization 
Glass slides were blinded and examined under a confocal microscope using Nikon NIS-Elements 
microscope imaging software on a computer. Confocal microscopy is a form of fluorescence 
14 
microscopy that allows for three-dimensional examination of cells and the generation of high-
resolution images. Galvano setting was used to obtain higher quality images of cells. One small 
rectangular ROI was inserted onto an area of a cell that had both green fluorescence and red 
fluorescence to determine colocalization. Three biologically independent replicates were 
Correlation Coefficient was used to determine whether there was significant colocalization 
















significantly lower nuclear-to-cytoplasmic ratios than wild-  
Since the mutations K136R, L251P, V390A, A225G, D246N, and G24E are all located within 
mutants would be different from that of wild-type ( HeLa cells were transfected with 
GFP- - -  A225G, D246N, E350K, and GFP-
K136R, L251P, V390A expression plasmids, fixed, and stained with DAPI, and analyzed by 




lower than that of wild-






















Figure 3: HeLa cells were transfected with GFP- - -
D246N, E350K, and GFP-
with DAPI, and analyzed by quantitative fluorescence microscopy. (A) In the images, green fluorescence 
indicates GFP- -stained nucleus. (B) In the graph, the bars 
indicate the relative N/C for mutant TR 1, normalized to the N/C ratio of wild-type, where wild-type was 









































Mutations in TR 1




from that of wild-  
Since the mutation E213D is located in 
K74E is not in an NLS/NES region, it was predicted that its nuclear-to-cytoplasmic ratio would 
not be sig
allosteric sensor that is involved in transcription regulation after binding to DNA. HeLa cells 
were transfected with GFP- - -
plasmids, fixed, and stained with DAPI, and analyzed by quantitative fluorescence microscopy to 
calculate the relative nuclear-to-cytoplasmic ratio (Figure 4). Usin -test, it was 
found that the relative nuclear-to-



























Figure 4: HeLa cells were transfected with GFP- - -
expression plasmids, fixed, and stained with DAPI, and analyzed by quantitative fluorescence 
microscopy. (A) In the images, green fluorescence indicates GFP- orescence indicates 
DAPI-stained nucleus. (B) In the graph, the bars indicate the relative N/C for mutant TR 1, normalized to 
the N/C ratio of wild-type, where wild-type was set at 1.0. Error bars indicate ± SEM (n=3 biologically 





































Mutations in TR 1




S40T, K136R, L251P, V390A 
In order to 
because -
(positively charged) to arginine (positively charged) or the change from valine (nonpolar) to 
alanine (nonpolar). HeLa cells were transfected with GFP- -
L251P, V390A, and GFP-
analyzed by quantitative fluorescence microscopy to calculate the relative nuclear-to-
cytoplasmic ratio (Figure 5 -





























Figure 5: HeLa cells were transfected with GFP- -
and GFP-
fluorescence microscopy. (A) In the images, green fluorescence indicates GFP-
fluorescence indicates DAPI-stained nucleus. (B) In the graph, the bars indicate the relative N/C for 
mutant TR 1, normalized to the N/C ratio of wild-type, where wild-type was set at 1.0. Error bars 




































Mutations in TR 1
Nuclear-to-Cytoplasmic Ratios of WT TR 1, TR 1 S40T, K136R, L251P, 
V390A, and TR 1 L251P
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A225G, D246N, E350K have aggregates than cells with wild-  
A225G, D246N, E350K were examined 
aggregates throughout the cells. HeLa cells were transfected with GFP- -
S40T, K136R, L251P, V390A, and GFP- A225G, D246N, E350K expression plasmids, 
fixed, and stained with DAPI, and analyzed by quantitative fluorescence microscopy to calculate 
the percentage of cells with or without aggregates (Figure 6 -test, it was 
found that the percentage of cells with smooth distribution is significantly higher among cells 
 
 
Figure 6: HeLa cells were transfected with GFP- -
and GFP- E350K expression plasmids, fixed, and stained with DAPI, and analyzed 
by quantitative fluorescence microscopy. Error bars indicate ± SEM (*=p p p 





Caveolin-1, a protein encoded by the CAV1 gene, is involved in numerous biological processes 
including transcytosis, endocytosis, and tumor suppression.  In one study, analysis of tissue 
samples from 160 HCC patients showed that patients with strong caveolin-1 expression had 
decreased overall survival rate. Overexpression of caveolin-1 has been repeatedly implicated in 
the angiogenesis and metastasis of hepatocellular carcinoma, as it increases cell growth and 
invasiveness of tumors (Tang et al., 2012). In another study, it was shown that a particular 
-1 in the plasma membrane (Hayer et al., 
2010). Along with the evidence linking caveolin-
similar to that of 
caveolin-1. Thus, the possibility of colocalization of the TR mutant and caveolin-1 was tested 
through confocal microscopy.  (PCC), which is denoted by r, 
was used to quantify colocalization. PCC can range from +1 to -1, with a value of 0 suggesting a 
lack of colocalization and a value of 1 indicating perfect colocalization. It is accepted that an r 
 (Adler and Parmryd, 2010). 
HeLa cells were transfected with mCherry-caveolin-1 and GFP-
V390A expression plasmids, fixed, and stained with DAPI, and analyzed by confocal 
microscopy to determine if caveolin-




























Figure 7: HeLa cells were transfected with mCherry-caveolin-1 and GFP-
V390A expression plasmids, fixed, and stained with DAPI. (A) In the images, red fluorescence indicates 
mCherry-caveolin-1, green fluorescence indicates GFP- e fluorescence indicates DAPI-
stained nucleus. (B) 
Error bars indicate ± SEM (n=3 biologically independent replicates, at least 25 cells 



















Caveolin-1 TR S40T, K136R, L251P, 
V390A




















Colocalization of Caveolin-1 and TR S40T, K136R, L251P, V390A
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Discussion 
It has previously been shown that mutations in TR may be contributing to the development of 
particular types of cancer, including hepatocellular carcinoma and papillary thyroid cancer. 
However, the reasons for this association are unclear. This thesis has demonstrated that certain 
cancer- ytoplasmic 
distribution of the mutant receptor relative to wild-
cell, which could disrupt gene expression. 
D246N, E350K showed a higher cytoplasmic distribution and a greater formation of aggregates, 
localization may occur in this particular mutant because, unlike leucine, proline forms a 
nitrogen- -helices. Considering that L251P is a 
mutation in the NES-H3/NES-
S40T, K136R, L251P, V390A has no T3 binding, the formation of kinks in the LBD may be 
disrupting the binding of T3 to TR and interfering with target gene transcription. These kinks 
could also be contributing to the formation of aggregates. 
350K, upon first look, it may seem as if it is unlikely that 
the change from alanine (a small non-polar amino acid) to glycine (a small non-polar amino 
acid) is leading to the observed mislocalization. However, there is evidence suggesting that the 
stability of a helix with alanine versus glycine varies based on the location of the helix within a 
protein and on their surrounding amino acids. More specifically, glycine leads to a more stable 
helix when the helix is at an N-terminal or a C-terminal location, but alanine allows for a more 
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stable helix when the helix is located internally within a protein (Serrano et al., 1992). Since the 
mislocalization and formation of aggregates. The change from aspartic acid (a negatively 
charged amino acid) to asparagine (a polar, neutral amino acid) located in the NES-H3/NES-H6 
region of LBD is also likely to be altering the cellular distribution of TR, since the structure and 
possible interactions of these amino acids are different. The conversion of glutamic acid (a 
negatively charged amino acid) to lysine (a positively charged amino acid) in the LBD could also 
be contributing to the formation of aggregates, but it is less likely that it is leading to higher 
cytoplasmic distribution since the mutation is not in an NLS or NES region. Both D246N and 
E350K could be leading to the formation of aggregates since their structures and interactions 
would be different. 
The TR 1 mutations L251P, A225G, and D246N all occur in the NES-H3/NES-H6 region of 
LBD. Considering that the NLSs and NESs are conserved among vertebrate species, the 
mutations in the NES region may be leading to decreased affinity for exportins. However, 
reduced affinity for exportins does not explain why the TR 1 mutants are showing a decreased 
nuclear-to-cytoplasmic ratio compared to WT TR 1; exportins transport TR 1 out of the 
nucleus, and reduced affinity to exportins would indicate that the nuclear-to-cytoplasmic ratio of 
TR 1 would be higher than that of WT TR 1. One possibility for this unexpected cellular 
distribution may be that the mutations in the NES-H3/NES-H6 region interact with the other 
amino acids in TR 1 and are close enough to the hinge domain that they could be altering the 
structure of the NLSs of TR 1, disrupting the binding of importins to the NLSs. Such disruption 
would prevent TR 1 from entering the nucleus, leading to the observed decrease in its nuclear-
to-cytoplasmic ratio. Another possibility is that the mutations in the NES region may be leading 
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to increased affinity for exportins. In this case, the exportins would more efficiently transport 
 in nuclear-to-cytoplasmic ratio. However, 
increased affinity is unlikely because, although NES consensus sequences are not well-defined, it 
has been repeatedly observed that they tend to be hydrophobic (Kosugi et al., 2008)
mutations L251P, A225G, and D246N probably do not increase hydrophobicity of the NES-
H3/NES-H6 region because proline and asparagine are not hydrophobic, and alanine and glycine 
are both hydrophobic. 
greater 
this mutation is in the NLS-2 region of A/B domain, the NLS-2 of the TR mutant may not be 
recognized by an importin and the TR mutant may not be transported into the nucleus as 
efficiently -polar amino acid while glutamic acid is 
a negatively charged amino a
possibly interfere with the binding of T3  
In contrast
 NES-H3/NES-H6 region of LBD, both glutamic acid and 
be affected enough to change the localization
conversion from lysine (a positively charged amino acid) to glutamic acid (a negatively charged 
amino acid), the mutation does not occur in an NLS or NES region so the localization of the 
 
In summary, it seems as if mutations in the NLS or NES regio  tertiary 
structure are likely to lead to a decrease in the nuclear-to- . If 
these mutations occur in the LBD, then the mutant  proteins are likely to form aggregates. 
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 and development, such alterations 
cancer progression. 
Protein Aggregation Diseases 
Protein aggregation diseases are diseases that are known to develop or progress due to 
aggregation of misfolded proteins within or outside cells. These include neurodegenerative 
Amyotrophic Lateral Sclerosis (ALS), which are characterized by the aggregation of -peptide, 
-synuclein, Huntingtin, and ubiquitinated proteins, respectively. Protein aggregation occurs 
when hydrophobic amino acids that are normally buried within the protein become exposed to 
the aqueous environment inside the cell. When multiple misfolded proteins with exposed 
hydrophobic amino acids interact with one another, hydrophobic forces cause the proteins to 
aggregate. Protein aggregation can also occur if misfolded proteins have a greater tendency to 
-sheets or have a lower net charge than wild-type proteins (Kumar et al., 2016). In 
neurodegenerative diseases, protein aggregates have often been associated with mitochondrial 
dysfunction, oxidative stress, and chronic inflammation. (Rego and Oliveira, 2003). This 
association is interesting because chronic inflammation is a major risk factor for many types of 
cancer, including hepatocellular carcinoma (Coussens and Werb, 2002). In this way, the TR 1 
mutant aggregates could be leading to oxidative stress and chronic inflammation, contributing to 





Based on the data presented in this thesis, mutations in the NES-H3/NES-H6 region of the LBD 
uld be interesting to observe 
structures may allow for a better understanding of the reasons for mislocalization. In the 
tations, using protein prediction software would help 
clarify the interactions between the regions with mutations. Predicting the protein structure could 
also reveal the possible causes of aggregate formation. Previous research has shown that 
aggregate for -sheets, 
and have low net charge (Kumar et al., 2016). Also, there is evidence suggesting that regions of 
proteins that have reverse turns are important for proper protein folding. All of these factors 
could be accounted for when visualizing and analyzing mutated proteins through protein 
structure prediction. 
understand the implications of the aggregates. Characterization of small aggregates can be 
conducted by utilizing mass spectrometry a technique that ionizes samples and determines their 
mass-to-charge ratios, allowing unknown compounds in a sample to be identified. 
Lastly, it has been previously shown that formation of aggregates may lead to mitochondrial 
dysfunction and overexpression of proinflammatory cytokines, which can cause chronic 
inflammation. For example, it has been demonstrated that misfolded protein aggregates can lead 
to accumulation of metabolites; both the aggregates and metabolites can then localize to 
mitochondria-associated membranes and trigger ER stress, stimulate production of reactive 
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oxygen species, and activate NLRP3 inflammasome (Missiroli et al., 2018)
would be interesting to analyze HeLa cells that are cotransfected with a TR 1 mutant and a 
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